A Lehigh Valley company that helped transform HIV testing is continuing its mission to improve public health through innovation and accessibility.

On the first day for its new CEO, Veracyte is keeping him busy by unveiling an acquisition that aims to dramatically widen the company’s global footprint in cancer diagnostics. The company’s €260 ...

Exagen, which sells blood tests that can diagnose, prognose, or monitor autoimmune diseases, announced terms for its IPO on Monday. The Vista, CA-based company plans to raise $50 million by offering 3 ...

Australian diagnostics test maker Ellume will lease two buildings in Frederick, Maryland, for its first U.S.-based manufacturing operations, and will create 1,500 jobs by the end of 2022. Ellume’s ...

Covid-19 test maker Cue Health went public on Friday at a valuation of nearly $2.3 billion. Shares opened above the $16 price set the night before and closed at $20—a 25% increase in the first day of ...

As a test taker, you will be more skilled if you know how a test maker thinks. Your test taking strategies must anticipate the test maker's strategies. As a test taker, you will be more skilled if you ...